Thromboembolic complications in patients with clear cell carcinoma of the ovary

Gynecologic Oncology

Volumn 104, Issue 2, 2007, Pages 406-410

  Matsuura, Yusuke ^a   Robertson, Greg ^a   Marsden, Donald E ^a   Kim, Soo Nyung ^a   Gebski, Val ^b   Hacker, Neville F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clear cell carcinoma; Deep venous thrombosis; Ovary; Pulmonary embolism

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ASCITES; CANCER PATIENT; CLEAR CELL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; THROMBOEMBOLISM; UNIVARIATE ANALYSIS;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 33846356094     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.08.026     Document Type: Article

References (27)

1. Trousseau A. Phlegmasia alba dolens. Clinique Medicale del'Hotel-Dieu de Paris 3 (1865), New Sydenham Society, London 94
2. Sallah S., Wan J.Y., and Nguyen N.P. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb. Haemost. 87 (2002) 575-579
3. Svendsen E., and Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J. Clin. Pathol. 42 (1989) 805-809
4. Shlebak A.A., and Smith D.B. Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and/or hormonal therapy. Cancer Chemother. Pharmacol. 39 (1997) 462-466
5. Naschitz J.E., Yeshurun D., and Lev L.M. Thromboembolism in cancer. Changing Trends Cancer 71 (1993) 1384-1390
6. von Tempelhoff G.F., Nieman F., Heilmann L., and Hommel G. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy. Clin. Hemorheol. Microcirc. 22 (2000) 107-130
7. Miller B., and Heilmann L. Hemorheological parameters in patients with gynecologic malignancies. Gynecol. Oncol. 33 (1989) 177-181
8. Goodnight Jr. S.H. Bleeding and intravascular clotting in malignancy: a review. Ann. N. Y. Acad. Sci. 230 (1974) 271-288
9. Gore M., Miller K.E., Soong S.J., Clarke-Pearson D.L., and Pizzo S.V. Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies. Am. J. Obstet. Gynecol. 149 (1984) 830-834
10. Crandon A.J., and Koutts J. Incidence of post-operative deep vein thrombosis in gynaecological oncology. Aust. N. Z. J. Obstet. Gynaecol. 23 (1983) 216-219
11. Cyrkowicz A. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin. Gynecological ward retrospective analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 100 (2002) 223-226
12. Recio F.O., Piver M.S., Hempling R.E., and Driscoll D.L. Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 78 (1996) 2157-2163
13. von Tempelhoff G.F., Pollow K., Schneider D., and Heilmann L. Chemotherapy and thrombosis in gynecologic malignancy. Clin. Appl. Thromb. Hemost. 5 (1999) 92-104
14. Canney P.A., and Wilkinson P.M. Pulmonary embolism in patients receiving chemotherapy for advanced ovarian cancer. Eur. J. Cancer Clin. Oncol. 21 (1985) 585-586
15. Planner R.S., O'Sullivan E.F., Campbell J.J., and Ball D.L. The hypercoagulable state and pulmonary embolism in patients with ovarian carcinoma. Aust. N. Z. J. Obstet. Gynaecol. 18 (1978) 209-212
16. Nakayama M., Iha T., and Kanazawa K. Unusual Trousseau's syndrome in ovarian carcinosarcoma: multiple systemic thromboembolic events. J. Obstet. Gynaecol. 22 (2002) 699-700
17. Jain V., Bali H., Kalra J., Gopalan S., Bhargava M., and Saha S. Preoperative vena caval interruption for venous thrombosis associated with ovarian malignancy. Acta Obstet. Gynecol. Scand. 81 (2002) 270-271
18. Evans T.R., Mansi J.L., and Bevan D.H. Trousseau's syndrome in association with ovarian carcinoma. Cancer 77 (1996) 2544-2549
19. Hines J.F., Tucker A., Grendys E.C., Ascher S.M., and Barter J.F. Spontaneous preoperative internal jugular and subclavian vein thrombosis associated with an early-stage synchronous ovarian/endometrial malignancy. Gynecol. Oncol. 56 (1995) 298-301
20. Viselli A.L., Feuer G.A., and Granai C.O. Lower limb ischemic venous thrombosis in patients with advanced ovarian carcinoma. Gynecol. Oncol. 49 (1993) 262-265
21. Goff B.A., Cuesta R.S., Muntz H.G., Fleischhacker D., Ek M., Rice L.W., et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in Stage III disease. Gynecol. Oncol. 60 (1996) 412-417
22. O'Brien M.E.R., Schofield J.B., Tan S., Fryatt I., Fisher C., and Wiltshaw E. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol. Oncol. 49 (1993) 250-254
23. Behbakht K., Randall T.C., Benjamin I., Morgan M.A., King S., and Rubin S.C. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol. Oncol. 70 (1998) 255-258
24. Jenison E.L., Montag A.G., Griffiths C.T., Welch W.R., Lavin P.T., Greer J., et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol. Oncol. 32 (1989) 65-71
25. Yoonessi M., Weldon D., Satchidand S.K., and Crickard K. Clear cell ovarian adenocarcinoma. J. Surg. Oncol. 27 (1984) 289-297
26. von Tempelhoff G.F., Heilmann L., Hommel G., Schneider D., Niemann F., and Zoller H. Hyperviscosity syndrome in patients with ovarian carcinoma. Cancer 82 (1998) 1104-1111
27. von Tempelhoff G.F., Niemann F., Schneider D.M., Kirkpatrick C.J., Hommel G., and Heilmann L. Blood rheology during chemotherapy in patients with ovarian cancer. Thromb. Res. 90 (1998) 73-82